Hetero Labs Limited Letrozole Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Letrozole Export Records India — #14 Exporter, 6 Shipments, $117.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Hetero Labs Limited — Letrozole Exporter #14 | $117.1K Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Letrozole Exporter Profile

Indian Pharmaceutical Exporter · #14 for Letrozole · $117.1K export value · DGFT Verified

Hetero Labs Limited is the #14 Indian exporter of Letrozole with $117.1K in export value and 6 verified shipments. Hetero Labs Limited holds a 0.4% market share in Letrozole exports across 4 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Letrozole Export Profile: Buyers & Destinations

Hetero Labs Limited Letrozole export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Letrozole?

Country	Value	Shipments	Share
UNITED STATES	$3.9M	119	25.8%
UNITED KINGDOM	$2.2M	165	14.9%
PHILIPPINES	$1.6M	126	10.8%
THAILAND	$1.4M	27

Who Are the Top Buyers of Letrozole from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$1.5M	42
ACCORD UK	UNITED KINGDOM	$1.4M	49
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$933.2K	23
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$605.3K	34
THE GOVERNMENT PHARMACEUTICAL	THAILAND	$500.0K	10
APOTEX AUSTRALIA	AUSTRALIA	$481.7K	18
AUROBINDO PHARMA USA., INC,	UNITED STATES	$418.6K	18
MULTICARE PHARMACEUTICALS PHILIPPIN	PHILIPPINES	$350.0K	7
PHARMALAND (1982) CO. LTD	THAILAND	$250.0K	5
SUN PHARMA PHILIPPINES INC.	PHILIPPINES	$200.0K	4

India's Letrozole is purchased by 508 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by ACCORD UK and EVERSANA LIFE SCIENCES SERVICES LLC.

How Does Hetero Labs Limited Compare to Nearest Letrozole Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	GLOBELA PHARMA PRIVATE LIMITED	$154.0K	9	2	$17.1K
13	SUN PHARMACEUTICAL INDUSTRIES LTD	$120.1K	4	2	$30.0K
14	HETERO LABS LIMITED ★	$117.1K	6	4	$19.5K
15	KWALITY PHARMACEUTICALS LIMITED	$115.5K	18	4	$6.4K

Hetero Labs Limited ranks #14 among 252 Indian Letrozole exporters. Average shipment value of $19.5K compared to the market average of $74.0K. The closest competitors by value are GLOBELA PHARMA PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD.

Which Indian Ports Ship Letrozole Exports?

Port	Shipments	% Share
SAHAR AIR	404	19.1%
SAHAR AIR CARGO ACC (INBOM4)	393	18.6%
MUNDRA SEA (INMUN1)	109	5.2%
AHEMDABAD AIR ACC (INAMD4)	107	5.1%
MUNDRA SEA	102	4.8%
DELHI AIR CARGO ACC (INDEL4)	100	4.7%
Bombay Air	99	4.7%
HYDERABAD AIR	89	4.2%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Letrozole Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Letrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 117+ countries, 508+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Letrozole

Letrozole

Hetero Labs Limited — Letrozole Exporter Profile

Hetero Labs Limited — Letrozole Export Profile: Buyers & Destinations

Where Does India Export Letrozole?

Who Are the Top Buyers of Letrozole from India?

What Is India's Total Letrozole Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Letrozole Exports?

How Does Hetero Labs Limited Compare to Other Indian Letrozole Exporters?

Regulatory Requirements: Exporting Letrozole to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Hetero Labs Limited Compare to Nearest Letrozole Exporters?

Which Indian Ports Ship Letrozole Exports?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Letrozole Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Letrozole Export Data from Hetero Labs Limited

Letrozole Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source